Table 3.

Survivin, XIAP and XAF1 immunoreactivity.

		Survivin		XIAP		XAF1
	IHC score*	n	(%)	n	(%)	n	(%)
HCC	Negative	-		7	17,5%	23	57,5%
	Low	22	55,0%	23	57,5%	17	42,5%
	High	18	45,0%	10	25,0%	-
Adjacent liver#	Negative	-		10	25,0%	21	52,5%
	Low	2	5,0%	19	47,5%	19	47,5%
	High	38	95,0%	11	27,5%	-
Non-adjacent liver#	Negative	-		12	30,0%	25	62,5%
	Low	1	2,5%	18	45,0%	15	37,5%
	High	39	97,5%	10	25,0%	-

The number (n) and the percentage of patients (%) in each IHC category are indicated.

*Negative (score 0), Low (score 1–6) and High (score 7–12).

#Adjacent liver: liver parenchyma at less than 1 cm from the tumor; non-adjacent liver: liver parenchyma at more than 3 cm from tumor.